PAR

1.92%

25.5¢ paradigm biopharmaceuticals limited..

most of us are too heavily invested and down on our investment...

First 52 Last

Share
Profile

Follow
bobsee

233 Posts.

29

06/04/24

16:02

Post #: 73220785
Share

Originally posted by 39KP: ↑

I get it that no news + low cash + shares at 33c cause concern. but why are people saying that we are going bust in 6 weeks ?

they are getting a peer review as promised

they are trying to get the dose approved

they are trying to sort funding.

they are speaking to partners

given they have lots of data to show the fda (is this a bad thing ?) the fda have asked for a different pathway and will revert in June hopefully.

if people expect daily updates they are mistaken. if you think shares going down when Nasdaq / S&P have the worst day in 6 months is cause for concern then ok, but I don't see what it has to do with par or any other small cap I own.

is any big fund buying bc we are at 10% of our highs ? no. they are professionals and don't take punts. they will wait for the fda decision/ tga / peer review / breakthrough or whatever is coming down the pipe.

I am not saying all is well and this stock is going to the moon. I am just saying let's focus on the fact that they are discussing right now with the fda etc. if we don't get 2x2 and if we can't get cash etc then I will probably sell too. but am I selling because simon and Paul are not telling us regularly exactly what they are up to ? no

it seems this forum is either high as a kite or near suicidal.

everyone says these guys are incompetent etc etc etc. Apple just shut down their car project after 5+ years and billions of dollars. sometimes it doesn't work out. even for the best.

par is taking longer than we all hoped. are they morons ? I don't know, is Tim Cook a moron ? I say no.

I could go on but if you don't like the quiet periods / if u don't like management/ If u think they are going bust then sell.

why anyone would stay invested and spend time on HC if they think a company has 60/90 days to survive is beyond me

Expand

most of us are too heavily invested and down on our investment to get out now...too late...just hope theres a turnaround soon.

PAR Price at posting: 33.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

There are more pages in this discussion • 570 more messages in this thread...

First 52 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change -0.005(1.92%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
27.0¢	27.0¢	25.5¢	$261.4K	990.7K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	9445	1

View Market Depth

No.	Vol.	Price($)
1	9999	0.255
5	259000	0.250
4	96000	0.245
9	261374	0.240
5	71970	0.235

Price($)	Vol.	No.
0.260	9445	1
0.275	44000	2
0.280	35900	3
0.285	6729	2
0.290	60000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PAR (ASX) Chart

most of us are too heavily invested and down on our investment...

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

most of us are too heavily invested and down on our investment...

Top Stories

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News